Aim To evaluate the relevance of incidental prostate [18F] FDG uptake (IPU) and to explore
the potential of radiomics and machine learning (ML) to predict prostate cancer (PCa) …

With the high incidence of urogenital tumors worldwide, urinary system tumors are among
the top 10 most common tumors in men, with prostate cancer ranking first and bladder …

Microsatellite instability-high (MSI-H) is a tumor-agnostic biomarker for immune checkpoint
inhibitor therapy. However, MSI status is not routinely tested in prostate cancer, in part due to …

Purpose: To conduct a systematic review and network meta-analysis (NMA) to compare the
efficacy of currently available combination therapies in patients with metastatic hormone …

Abstract Background and Objective Androgen-deprivation therapy is the mainstay of
treatment for patients with newly diagnosed metastatic hormone-sensitive prostate cancer …

Purpose To quantify and assess the distribution of MR fingerprinting (MRF)-derived T1 and
T2 values of the whole prostatic peripheral zone (PZ), and perform subgroup analyses …

To present rectal endoscopic findings and toxicity after definitive moderately
hypofractionated, intensity-modulated radiotherapy (IMRT) for prostate cancer. We …

The proposed trial is to examine the feasibility of prostate-specific membrane antigen
(PSMA) positron emission tomography/computed tomography (PET/CT)-guided …

Background: Prostate cancer (PC) has a serious public health impact, and its incidence is
rising due to the aging population. There is limited evidence and consensus to guide the …

Background and objective Adherence to guideline recommendations can improve the
quality of care for patients with prostate cancer (PCa). Our aim was to assess adherence to …